IMU

4.26%

4.5¢ imugene limited

PFS (progression-free survival) - the length of time during and...

First 34 Last

Share
Profile

Follow
QiQi

588 Posts.

68

02/03/19

10:16

Post #: 37629102
Share

Originally posted by Steini: ↑

Ok, I've been trying to get myself through the "confusion" and came up with the following:

from the B-Vaxx publication link, anns, 26 Feb.

Patient 2C received seven 6 months booster vaccinations. Patient 2C travelled to Columbus, Ohio from Seattle, Washington to receive his first vaccine on 05/30/2012 and two boosters at 3 weeks apart. The patient returned every 6 months through 12/10/2015 to receive the 7 booster vaccinations, spanning 3.5 years. Prior to enrollment in our study, this patient was diagnosed with T2N2bM0 poorly differentiated carcinoma of the right parotid gland and underwent radical parotidectomy and selective right neck dissection. The surgical pathology revealed 25 lymph nodes positive for metastatic disease. Interestingly, the tumor also had "patchy foci" of 3+ Her2/neu staining based on immunohistochemistry on a background of equivocal 2+ positivity. Recurrence was discovered in the right axillary lymph nodes about 2 years later and the patient underwent right axillary lymph node dissection which revealed that four of 46 lymph nodes were positive. He was subsequently enrolled in our study. The exceptional response in this patient may also be due to the fact that this patient did not receive any chemotherapy prior to enrollment. Thus, his immune system was very much intact and likely more responsive to vaccine treatment. This is an important fact as the vaccine therapy should be more effective in such patients.

Plus, PFS of 41 months according to page 13, IMU-Website Wholesale-Presentation Feb-March, of patient 2C.

That indicated to me a Complete Response but I guess it is not.

2. I compared the Investor-Preso from 10-01-2019 with the current Wholesale-Preso and discovered like many here the differences / changes / additions.

When I wrote my previous posts I had the January's Investor-Preso in mind a I just got that stored on my phone.

I agree it is strange they did not highlight the amendments / additions in an extra anns, especially the 1 CR page 9 which we were not informed about. Let's hope it is not just a typo.

But in the end the most important fact is the 2 vaxx represent the new and more effective way in cancer treatment and that's what counts.

SP and MC haven't changed much but it won't take long I guess. Just a few Bio-tech US investors / pharma need to read that and it could explode the next morning.

And yes, IMU has to improve the way they communicate to / with us.

GLTA

Expand

PFS (progression-free survival) - the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse".

That doesn't equate to a Complete Reponse.
It was actually mentioned in the same presentation as the Complete Response patient for HER-Vaxx.

Last edited by QiQi: 02/03/19

IMU Price at posting: 2.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin jumps 8% to beat record on Trump vote optimism

SI6

Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits

RLF

Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62%

There are more pages in this discussion • 11 more messages in this thread...

First 34 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.5¢		Change -0.002(4.26%)		Mkt cap ! $386.7M

Open	High	Low	Value	Volume
4.7¢	4.8¢	4.4¢	$890.8K	19.42M

Buyers (Bids)

No.	Vol.	Price($)
2	176601	4.5¢

Sellers (Offers)

Price($)	Vol.	No.
4.6¢	969572	8

View Market Depth

No.	Vol.	Price($)
18	5665336	0.018
14	3997559	0.017
6	2974375	0.016
10	3219799	0.015
4	497500	0.014

Price($)	Vol.	No.
0.019	400000	2
0.020	5410946	12
0.021	8494780	17
0.022	8757253	13
0.023	4826614	8

Last trade - 16.10pm 06/11/2024 (20 minute delay)

IMU (ASX) Chart

PFS (progression-free survival) - the length of time during and...

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin jumps 8% to beat record on Trump vote optimism

Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits

Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PFS (progression-free survival) - the length of time during and...

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin jumps 8% to beat record on Trump vote optimism

Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits

Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News